Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingwei Luo

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Radiation Oncology (London, England)|January 22, 2022
Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategiesYi Xu, Yang Liu, Zekun Wang, et al.
The Laryngoscope|November 2, 2022
Synchronous Second Primary Cancers of Hypopharyngeal Carcinoma in the Image-Enhanced Endoscopy EraXi Luo, Xiaodong Huang, Shaoyan Liu, et al.
JAMA Network Open|February 22, 2022
Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal CarcinomaXi Luo, Xiaodong Huang, Shaoyan Liu, et al.
Oncotarget|February 10, 2017
Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinomaJunlin Yi, Xiaodong Huang, Zhengang Xu, et al.
The Lancet Regional Health. Western Pacific|August 16, 2024
Evidence of being cured for nasopharyngeal carcinoma: results of a multicenter patient-based study in ChinaYang Liu, Xin Liu, Shiran Sun, et al.
JCO Precision Oncology|January 5, 2023
Improved Cancer-Specific Risk Stratification by the Lymph Node Ratio-Based Nomogram: A Potential Role in Guiding Postoperative Management Decisions for Oral Cavity CarcinomaYang Liu, Yuchao Ma, Gulidanna Shayan, et al.
Therapeutic Advances in Medical Oncology|September 15, 2025
Combination of immunotherapy-based systemic therapy and radiotherapy achieves durable response and favorable survival in recurrent head and neck cancerJingbo Wang, Gulidanna Shayan, Xin Guo, et al.
Cancer Medicine|May 7, 2021
Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillanceJingbo Wang, Xiaodong Huang, Shiran Sun, et al.
BMC Cancer|November 29, 2022
Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trialXi Luo, Xiaodong Huang, Jingwei Luo, et al.
Frontiers in Immunology|November 28, 2022
Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancerFengge Zhou, Gulidanna Shayan, Shiran Sun, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Radiation Oncology (London, England)|January 22, 2022
Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategiesYi Xu, Yang Liu, Zekun Wang, et al.
The Laryngoscope|November 2, 2022
Synchronous Second Primary Cancers of Hypopharyngeal Carcinoma in the Image-Enhanced Endoscopy EraXi Luo, Xiaodong Huang, Shaoyan Liu, et al.
JAMA Network Open|February 22, 2022
Response-Adapted Treatment Following Radiotherapy in Patients With Resectable Locally Advanced Hypopharyngeal CarcinomaXi Luo, Xiaodong Huang, Shaoyan Liu, et al.
Oncotarget|February 10, 2017
Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinomaJunlin Yi, Xiaodong Huang, Zhengang Xu, et al.
The Lancet Regional Health. Western Pacific|August 16, 2024
Evidence of being cured for nasopharyngeal carcinoma: results of a multicenter patient-based study in ChinaYang Liu, Xin Liu, Shiran Sun, et al.
JCO Precision Oncology|January 5, 2023
Improved Cancer-Specific Risk Stratification by the Lymph Node Ratio-Based Nomogram: A Potential Role in Guiding Postoperative Management Decisions for Oral Cavity CarcinomaYang Liu, Yuchao Ma, Gulidanna Shayan, et al.
Therapeutic Advances in Medical Oncology|September 15, 2025
Combination of immunotherapy-based systemic therapy and radiotherapy achieves durable response and favorable survival in recurrent head and neck cancerJingbo Wang, Gulidanna Shayan, Xin Guo, et al.
Cancer Medicine|May 7, 2021
Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillanceJingbo Wang, Xiaodong Huang, Shiran Sun, et al.
BMC Cancer|November 29, 2022
Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trialXi Luo, Xiaodong Huang, Jingwei Luo, et al.
Frontiers in Immunology|November 28, 2022
Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancerFengge Zhou, Gulidanna Shayan, Shiran Sun, et al.
Pageof 8